Fresenius Medical Care Ag & Co. Kgaa (NYSE: FMS) reported Q2 EPS of $0.96, $0.04 better than the analyst estimate of $0.92. Revenue for the quarter came in at $4.42 billion versus the consensus estimate of $4.54 billion.

For earnings history and earnings-related data on Fresenius Medical Care Ag & Co. Kgaa (FMS) click here.